Evans Thomas George 4
4 · Vaccitech plc · Filed Feb 11, 2022
Insider Transaction Report
Form 4
Vaccitech plcVACC
Evans Thomas George
Chief Scientific Officer
Transactions
- Award
Share Option (Right to Buy)
2022-01-03+80,000→ 80,000 totalExercise: $11.12Exp: 2032-01-03→ Ordinary Shares (80,000 underlying)
Footnotes (2)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 3, 2023.